TSOI's STEMVACS/JADICELL MSCs have multiple functi

TSOI's STEMVACS/JADICELL MSCs have multiple functions within the immune system, affecting many different immune cell types and have the ability to suppress T-cell proliferation, cytokine secretion and regulate the balance of antibody-based and cell-based immune responses.

They also are capable of inhibiting the activation of dendritic cells and blocking the ability of dendritic cells to present antigens to other cells in the immune system. MSCs can also tone down the abnormal release of either antibodies from B-cells or cytokines from natural killer cells.

TSOI's in cellular therapy STEMVACS/JADICELL platform represents the culmination of extensive research and development that leverages the company’s scientific and clinical expertise in STEMVACS cellular therapy and JADICELL stem cell.

TSOI's STEMVACS/JADICELL could offer a unique and efficacious approach to treat the potentially fatal acute respiratory distress syndrome, multi-system inflammatory syndrome and cytokine storm-related to severe cases of COVID-19. Accumulating evidence has revealed that aberrant and excessive immune responses evoked by a SARS-CoV-2 virus infection are involved in lung damage and multi-organ injury seen in some patients with moderate and severe COVID-19.